Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Advances in the systemic treatment of leptomeningeal cancerTaher Abu Hejleh, Gerald Clamon
Translational Lung Cancer Research|February 11, 2021
Narrative review: mesenchymal-epithelial transition inhibitors-meeting their targetDanish Safi, Taher Abu Hejleh, Muhammad Furqan
Critical Reviews in Oncology/Hematology|November 2, 2019
The clinical significance of soluble PD-1 and PD-L1 in lung cancerTaher Abu Hejleh, Muhammad Furqan, Zuhair Ballas, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|September 15, 2018
Cancer care for adolescents and young adults in JordanHikmat Abdel-Razeq, Maha Barbar, Taher Abu Hejleh, et al.
Familial Cancer|March 28, 2015
Germline mutations predisposing to non-small cell lung cancerGerald H Clamon, Aaron D Bossler, Taher Abu Hejleh, et al.
Translational Lung Cancer Research|May 17, 2023
Activity of osimertinib in a patient with stage IV non-small cell lung cancer harboring HER2 exon 19, p.L755P mutation: case reportGudbjorg Jonsdottir, Mark Smith, Samuel Wood, et al.
American Journal of Ophthalmology Case Reports|March 10, 2022
Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancerMatthew G Field, H Culver Boldt, Taher Abu Hejleh, et al.
Current Oncology Reports|April 26, 2012
Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancersTaher Abu-Hejleh, James J Mezhir, Michael J Goodheart, et al.
Clinical Breast Cancer|September 24, 2014
Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012Mary C Schroeder, Charles F Lynch, Taher Abu-Hejleh, et al.
Pageof 5